Head to Head Survey: PROCEPT BioRobotics (NASDAQ:PRCT) and Micron Solutions (OTCMKTS:MICR)

Micron Solutions (OTCMKTS:MICR) and PROCEPT BioRobotics (NASDAQ:PRCT) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations.

Valuation & Earnings

This table compares Micron Solutions and PROCEPT BioRobotics”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Micron Solutions	N/A	N/A	N/A	($0.32)	0.00
PROCEPT BioRobotics	$308.05 million	4.59	-$95.57 million	($1.71)	-14.66

Micron Solutions has higher earnings, but lower revenue than PROCEPT BioRobotics. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than Micron Solutions, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of recent ratings for Micron Solutions and PROCEPT BioRobotics, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Micron Solutions	0	0	0	0	0.00
PROCEPT BioRobotics	2	4	8	0	2.43

PROCEPT BioRobotics has a consensus target price of $40.82, indicating a potential upside of 62.82%. Given PROCEPT BioRobotics’ stronger consensus rating and higher possible upside, analysts plainly believe PROCEPT BioRobotics is more favorable than Micron Solutions.

Profitability

This table compares Micron Solutions and PROCEPT BioRobotics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Micron Solutions	N/A	N/A	N/A
PROCEPT BioRobotics	-31.02%	-25.13%	-18.63%

Volatility and Risk

Micron Solutions has a beta of 0.04, meaning that its stock price is 96% less volatile than the S&P 500. Comparatively, PROCEPT BioRobotics has a beta of 1.02, meaning that its stock price is 2% more volatile than the S&P 500.

Insider & Institutional Ownership

89.5% of PROCEPT BioRobotics shares are held by institutional investors. 26.1% of Micron Solutions shares are held by company insiders. Comparatively, 6.6% of PROCEPT BioRobotics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

About Micron Solutions

Micron Solutions, Inc. operates as a contract manufacturer for the medical device, defense, and life sciences markets. It offers precision machining, thermoplastic injection molding, mold making products; sensors; orthopedic implants and devices; and diagnostic test kits. The company provides solutions for medical, orthopedics, consumer, and automotive industries. Micron Solutions, Inc. was founded in 1978 and is based in Fitchburg, Massachusetts.

About PROCEPT BioRobotics

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.